ILMN Illumina, Inc.

NASDAQ
$270.00

Illumina, Inc. (ILMN) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is $1.36 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +32.8% since its last earnings release on July 30, 2026.

Illumina Beat Consensus Estimates, Raises Guidance
Thursday, July 30, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:05 PM ET
Earnings Whisper
-
vs $1.36
Rev est $1.14B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $221.59

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Illumina, Inc.

Illumina Inc provides sequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 10 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.